Clinical Trial Update: Molecular and ctDNA Characterization of High-Risk Endometrial Cancer

View source ↗

Summary

A Mayo Clinic-backed clinical trial is investigating molecular and ctDNA characterization in high-risk endometrial cancer to improve understanding of tumor biol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: Mayo Clinic | Conditions: Endometrial Carcinoma, Endometrial High Grade Endometrioid Adenocarcinoma | Status: RECRUITING